S-allylmercapto-N-acetylcysteine

an antioxidant with neuroprotective activity

Also Known As:

ASSNAC compound

Networked: 5 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Acyclic Hydrocarbons
    - Alkenes: 265
      - Allyl Compounds: 7
        S-allylmercapto-N-acetylcysteine: 5
- Sulfur Compounds: 278
  - Sulfur Amino Acids: 221
    - Cysteine: 6760
      - Acetylcysteine: 4440
        S-allylmercapto-N-acetylcysteine: 5
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Sulfur Amino Acids: 221
    - Cysteine: 6760
      - Acetylcysteine: 4440
        S-allylmercapto-N-acetylcysteine: 5

Experts

1.	Li, Genju: 2 articles (12/2021 - 09/2021)
2.	Wang, Jinglong: 2 articles (12/2021 - 09/2021)
3.	Zhao, Zhongxi: 2 articles (12/2021 - 09/2021)
4.	Zheng, Dandan: 2 articles (12/2021 - 09/2021)
5.	An, Lulu: 1 article (12/2021)
6.	Qu, Ying: 1 article (12/2021)
7.	Ye, Wenhui: 1 article (12/2021)
8.	Zhang, Qinxiu: 1 article (12/2021)
9.	Zhao, Xin: 1 article (12/2021)
10.	Deng, Qi: 1 article (09/2021)

Related Diseases

1.	Chronic Obstructive Pulmonary Disease (COPD) 12/01/2021 - "This study aimed to elucidate the protective effect of S-Allylmercapto-N-acetylcysteine (ASSNAC) against COPD via regulating the autophagy. " 12/01/2021 - "S-Allylmercapto-N-acetylcysteine ameliorates elastase-induced chronic obstructive pulmonary disease in mice via regulating autophagy."
2.	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/01/2023 - "S-allylmercapto-N-acetylcysteine ameliorates pulmonary fibrosis in mice via Nrf2 pathway activation and NF-κB, TGF-β1/Smad2/3 pathway suppression."
3.	Pulmonary Emphysema 09/01/2021 - "The objective of this work was to study the effects and mechanisms of S-allylmercapto-N-acetylcysteine (ASSNAC) in the treatment of pulmonary emphysema based on network pharmacology analysis and other techniques. " 09/01/2021 - "Preliminary therapeutic and mechanistic evaluation of S-allylmercapto-N-acetylcysteine in the treatment of pulmonary emphysema."
4.	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 08/01/2023 - "In this research, we sought to examine the effectiveness of S-allylmercapto-N-acetylcysteine (ASSNAC) on LPS-provoked acute respiratory distress syndrome (ARDS) and its potential mechanism based on network pharmacology. " 08/01/2023 - "Integrating network pharmacology and pharmacological evaluation to reveal the therapeutic effects and potential mechanism of S-allylmercapto-N-acetylcysteine on acute respiratory distress syndrome."
5.	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/07/2014 - "S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis."

Related Drugs and Biologics

1.	Pancreatic Elastase (Elastase)
2.	Therapeutic Uses